Are ECG abnormalities in Noonan syndrome characteristic for the syndrome? by R. Raaijmakers et al.
ORIGINAL PAPER
Are ECG abnormalities in Noonan syndrome characteristic
for the syndrome?
R. Raaijmakers & C. Noordam & J. A. Noonan &
E. A. Croonen & C. J. A. M. van der Burgt &
J. M. T. Draaisma
Received: 1 October 2007 /Accepted: 10 January 2008 / Published online: 13 February 2008
# The Author(s) 2008
Abstract Of all patients with Noonan syndrome, 50–90%
have one or more congenital heart defects. The most
frequent occurring are pulmonary stenosis (PS) and
hypertrophic cardiomyopathy. The electrocardiogram
(ECG) of a patient with Noonan syndrome often shows a
characteristic pattern, with a left axis deviation, abnormal
R/S ratio over the left precordium, and an abnormal Q
wave. The objective of this study was to determine if these
ECG characteristics are an independent feature of the
Noonan syndrome or if they are related to the congenital
heart defect. A cohort study was performed with 118
patients from two university hospitals in the United States
and in The Netherlands. All patients were diagnosed with
definite Noonan syndrome and had had an ECG and
echocardiography. Sixty-nine patients (58%) had character-
istic abnormalities of the ECG. In the patient group without
a cardiac defect (n=21), ten patients had a characteristic
ECG abnormality. There was no statistical relationship
between the presence of a characteristic ECG abnormality
and the presence of a cardiac defect (p=0.33). Patients with
hypertrophic cardiomyopathy had more ECG abnormalities
in total (p=0.05), without correlation with a specific ECG
abnormality. We conclude that the ECG features in patients
with Noonan syndrome are characteristic for the syndrome
and are not related to a specific cardiac defect. An ECG is
very useful in the diagnosis of Noonan syndrome; every
child with a Noonan phenotype should have an ECG and
echocardiogram for evaluation.
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Noonan syndrome is a relatively common multiple con-
genital anomaly syndrome, the incidence being estimated
by Nora et al. [19] between 1 per 1,000–2,500 live births.
Mendez and Opitz [13] consider the frequency to be even
higher, with 1 per 1,000 severely affected cases and 1 per
100 with mild expression. The syndrome was first
described as a distinct syndrome in 1963 by Noonan and
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Ehmke [15] who reported 9 patients with Turner-like
abnormalities but without the chromosomal pattern of
Turner syndrome. NS may occur on a sporadic basis or in
a pattern consistent with autosomal dominant inheritance.
In 1994 a gene was localized at the long arm of
chromosome 12 [9], and in 2001 the gene was identified
as the PTPN11 gene [27]. About 50% of Noonan syndrome
cases have PTPN11 mutations [25, 27]. PTPN11 encodes
the nonreceptor protein tyrosine phosphatase SHP-2. This
enzyme is involved in a wide variety of intracellular signal
cascades and is required in several developmental processes
[14, 25].
The main clinical features of Noonan syndrome are
characteristic facial features, short stature, and several
cardiac defects. Fifty to 90% of all Noonan patients have
one or more cardiac malformations. Presented most
frequently is pulmonary stenosis (pulmonary artery as well
as pulmonary valve stenosis), described in 50–62% of cases
[11, 17, 22, 24], while hypertrophic cardiomyopathy
(HCM) occurs in 20–30% [1, 11]. Atrial and/or ventricular
septal defects are mentioned in 5–15% of cases [11, 18, 24].
Some more rare malformations are coarctation of the aorta
and structural mitral valve abnormalities [1, 12, 18].
Patients with a PTPN11 gene mutation more often have
pulmonary stenosis, and patients without a PTPN11 gene
mutation more often have hypertrophic cardiomyopathy
[10, 26].
The electrocardiogram (ECG) of Noonan patients fre-
quently shows a characteristic pattern (Fig. 1). Typical
features mentioned are a left axis deviation with a negative
aVF, abnormal R/S ratio over the left precordium, and an
abnormal Q wave [5, 7, 23]. The cause of these
characteristic ECG features is still unknown. In this study
we quantify these characteristic ECG findings and evaluate
if the ECG characteristics are an independent diagnostic
entity, if they are related to the cardiac abnormalities found
by echocardiography in these patients, or if they are related
to the presence of a PTPN11 gene mutation in cases where
gene analysis was performed.
Patients and methods
An initial cohort of 166 patients with Noonan syndrome
from the United States (62 patients) and The Netherlands
(104 patients) was included in this study. All patients were
originally referred for suspected Noonan syndrome, short
stature, or cardiac defect to the University Hospitals of
Lexington, USA and Nijmegen, The Netherlands. The
diagnosis of Noonan syndrome was based on previously
published clinical criteria [16, 28] and confirmed by a
paediatric cardiologist (JN) or clinical geneticist (IvdB).
From the original cohort all patients who had undergone
both an ECG and an echocardiogram were selected.
Patients who had had surgical repair of the cardiac defects
before the available ECG was performed were excluded. In
this way our final study population was formed, consisting
of 118 patients (71% of the original cohort) of which there
were 70 males and 48 females. The median birth year of the
patients was 1985 (range 1930–1999). The median age at
which the ECG was performed was 6 years (range 0–
38 years). Thirty-six patients (31%)were tested for a
PTPN11 gene mutation, and in 26 patients a PTPN11 gene
mutation was found.
The electrocardiograms were reviewed by a paediatric
cardiologist who had no knowledge of the presence of a
cardiac malformation. The following characteristics were
scored:
1. Left axis deviation: a QRS axis less than the lower limit
of normal for the patient’s age according to Park [20].
2. An abnormal R/S ratio in V6: little R deflection over the
left precordium with an R/S ratio lower than the lower
limits of normal and R voltage in V5 and V6 less than 50%
of the mean according to Park and Guntheroth [8, 21].
3. Abnormal Q wave: a Q voltage greater than the upper
limit of normal and wider than 0.04 s [8].
The data were collected in SPSS and Excel. Compar-
isons between patient groups were made using Fisher exact
test, with a significance threshold of p≤0.05.
Fig. 1 A characteristic
electrocardiogram of a 3-month-
old male NS patient showing
left axis deviation and little
R deflection over the left
precordium
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Results
One or more congenital heart defects were present in 97 of
the 118 patients with Noonan syndrome. PS was present in
77 patients (65%), HCM in 20 patients (17%), and 12
patients (10%) had other cardiac defects (mitral valve
insufficiency, atrial septal defect, cleft mitral valve, aortic
insufficiency, aortic valve malformation). Forty-five
patients presented with more than one cardiac defect. Of
the patients with more than one cardiac defect, 11 patients
had PS in combination with HCM and 19 patients had PS
in combination with atrial septal defect. There were 21
patients (18%) without a congenital heart defect. Sixty-nine
patients (58%) had characteristic abnormalities of the ECG.
Fifty-nine of them (50%) had a left axis. Abnormal R/S
ratio over the left precordium was found in 24 patients
(20%) and 7 patients had an abnormal Q-wave on ECG.
Sixteen patients had two characteristic ECG abnormalities
and three patients had all three characteristic ECG
abnormalities.
In the 21 patients without a cardiac defect, ten had a
characteristic ECG abnormality. No statistical differences in
the occurrence of cardiac defects were seen between
patients with or without a characteristic ECG abnormality
(data not shown). There was no significant statistical
correlation between a specific ECG abnormality and the
presence of a cardiac defect, as is shown in Table 1. We
also evaluated the possible relationship between ECG
abnormalities and the most frequent cardiac defects, PS,
and HCM. There was no significant statistical correlation
between PS and one or more characteristic ECG abnormal-
ities (Table 2). For HCM there was a significant positive
correlation with the total of ECG abnormalities, but not
with a specific ECG abnormality (Table 2).
In the patient group that was tested for the occurrence of
a PTPN11 mutation (36 patients), no correlation was seen
between a characteristic ECG abnormality and the presence
or absence of a mutation (Table 1).
Discussion
In this study it is shown that ECG abnormalities found in
patients with Noonan syndrome are characteristic for the
syndrome. The presence of a congenital heart defect was
statistically independent from one of the characteristic ECG
features. Further, almost half of the patients without a
demonstrable congenital heart disease had the characteristic
ECG abnormalities for Noonan syndrome. However, the
patients with HCM had an abnormal ECG significantly
more often. In these patients this probably reflects the
ventricular hypertrophy. We formed an original cohort of all
referred patients for clinical suspicion of Noonan syn-
drome, short stature, and/or suspected cardiac defects to
prevent bias due to patients referred only for cardiac
reasons. However, some bias could still have occurred by
Table 1 Statistical analysis of

















ECG abnormalities 59 10 0.33 13 6 0.72
No ECG abnormalities 38 11 13 4
Left axis 50 9 0.63 12 5 1
No left axis 47 12 14 5
Little R 22 2 0.24 1 1 0.48
No little R 75 19 25 9
Abnormal Q 6 1 1 1 1 0.48
No Abnormal Q 91 20 25 9
Table 2 Statistical analysis of





Fisher exact test, PS pulmonary
stenosis, HCM hypertrophic
cardiomyopathy
PS No PS Fisher HCM No HCM Fisher
ECG abnormalities 42 25 0.56 16 53 0.05
No ECG abnormalities 35 16 4 45
Left axis 34 25 0.12 12 47 0.46
No left axis 43 16 8 51
Little R 18 6 0.34 5 19 0.55
No little R 59 35 15 79
Abnormal Q 5 2 1 1 6 1
No Abnormal Q 72 39 19 92
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selecting the patients who had undergone both an ECG and
echocardiography. Our patient group was representative in
the occurrence of cardiac defects as previously described
[1, 11, 17, 22, 24], with 65% PS, 17% HCM, and 10%
other defects in our cohort. There was no significant
difference in occurrence of cardiac defects or characteristic
ECG findings between the patients from The Netherlands
and the patients from the United States (data not shown).
With these results we assume there was no important bias in
our patient group by referral or selection.
The patients in whom mutation analysis was performed
did not significantly differ from the other patients with
respect to ECG abnormalities (Table 1) or with respect to
cardiac defects. In the genetically tested patients, no
differences in ECG abnormalities were found, but signifi-
cant differences were found with respect to the cardiac
defects. In the patients with a mutation, none had HCM, as
opposed to one third in the group without a mutation. This
is in concordance with previous observations, in which
HCM patients less often have a PTPN11 mutation [8, 9].
A typical electrocardiogram with a left axis and an
abnormal R/S ratio over the left precordium was first
described in Noonan patients in 1972 [7]. The electrocar-
diography was reported earlier as being useful in the
diagnosis of HCM [6], and Van der Burgt et al. [28]
proposed that a typical ECG can be of value in establishing
the diagnosis of Noonan syndrome. The present study
strongly supports this proposal.
The exact pathophysiology of the left QRS axis is still
unknown, but a possible explanation could be a counter-
clockwise rotation of the heart in combination with a
conduction defect abnormality [2, 3]. There are very few
data about the occurrence of one or more of these typical
ECG findings in otherwise healthy children. Only the
occurrence of a left axis deviation in healthy children has
been studied more extensively. Calcaterra et al. [4]
emphasize the unusual finding of a left axis deviation in
normal children, with an incidence of 1.4%. The other
characteristic ECG findings have not been reported in
healthy children in the literature to our knowledge. In this
study we showed that the above-mentioned ECG character-
istics occur in 58% of Noonan patients and that they are
independent of the presence of a demonstrable heart
disease. Therefore the ECG is a very useful, noninvasive
and relatively simple diagnostic tool in the diagnosis of
Noonan syndrome. Every child with Noonan phenotype
should have an ECG and echocardiogram for evaluation.
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